Yu, J., Luo, Y., Wang, L., Wang, T., Ye, M., Chen, J., . . . Yang, J. (2024). Effect of sustained measurable residue disease negativity and post‐remission treatment selection on the prognosis of acute lymphoblastic leukemia in adults. Cancer Medicine, 13(10), . https://doi.org/10.1002/cam4.7310
Chicago-referens (17:e uppl.)Yu, Jiechen, et al. "Effect of Sustained Measurable Residue Disease Negativity and Post‐remission Treatment Selection on the Prognosis of Acute Lymphoblastic Leukemia in Adults." Cancer Medicine 13, no. 10 (2024). https://doi.org/10.1002/cam4.7310.
MLA-referens (9:e uppl.)Yu, Jiechen, et al. "Effect of Sustained Measurable Residue Disease Negativity and Post‐remission Treatment Selection on the Prognosis of Acute Lymphoblastic Leukemia in Adults." Cancer Medicine, vol. 13, no. 10, 2024, https://doi.org/10.1002/cam4.7310.
